Gene · 3799
Papers2,390
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 2,390
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Acquired Tertiary MET Resistance (MET D1228N and a Novel LSM8-MET Fusion) to Selpercatinib and Capmatinib in a Patient With KIF5B-RET-positive NSCLC With Secondary MET Amplification as Initial Resistance to Selpercatinib. | J Thorac Oncol | 2021 | 34154791 | PubTator, text mining | PubMed |
| Kinesin-1-dependent transport of the βPIX/GIT complex in neuronal cells. | BMB Rep | 2021 | 34154701 | PubTator, text mining | PubMed |
| Comparison of microsatellite instability detection by immunohistochemistry and molecular techniques in colorectal and endometrial cancer. | Sci Rep | 2021 | 34145315 | PubTator, text mining | PubMed |
| Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS. | Nat Commun | 2021 | 34145282 | PubTator, text mining | PubMed |
| Synaptopathy Mechanisms in ALS Caused by C9orf72 Repeat Expansion. | Front Cell Neurosci | 2021 | 34140881 | PubTator, text mining | PubMed |
| Transcriptome and N6-Methyladenosine RNA Methylome Analyses in Aortic Dissection and Normal Human Aorta. | Front Cardiovasc Med | 2021 | 34124185 | PubTator, text mining | PubMed |
| Ethacrynic Acid Enhances the Antitumor Effects of Afatinib in EGFR/T790M-Mutated NSCLC by Inhibiting WNT/Beta-Catenin Pathway Activation. | Dis Markers | 2021 | 34122668 | PubTator, text mining | PubMed |
| Seminal exosomes - An important biological marker for various disorders and syndrome in human reproduction. | Saudi J Biol Sci | 2021 | 34121904 | PubTator, text mining | PubMed |
| [Research Progress of Fusion Genes RET in Non-small Cell Lung Cancer]. | Zhongguo Fei Ai Za Zhi | 2021 | 34120433 | PubTator, text mining | PubMed |
| Androgen receptor (AR) heterogeneity in prostate cancer and therapy resistance. | Cancer Lett | 2021 | 34118355 | PubTator, text mining | PubMed |
| MOGONET integrates multi-omics data using graph convolutional networks allowing patient classification and biomarker identification. | Nat Commun | 2021 | 34103512 | PubTator, text mining | PubMed |
| The L730V/I RET roof mutations display different activities toward pralsetinib and selpercatinib. | NPJ Precis Oncol | 2021 | 34099825 | PubTator, text mining | PubMed |
| Regulation of the NMDA receptor by its cytoplasmic domains: (How) is the tail wagging the dog? | Neuropharmacology | 2021 | 34097949 | PubTator, text mining | PubMed |
Guideline-Adherent Clinical Validation of a Comprehensive 170-Gene DNA/RNA Panel for Determination of Small Variants, Copy Number Variations, Splice Variants, and Fusions on a Next-Generation Sequencing Platform in the CLIA Setting. | Front Genet | 2021 | 34093633 | PubTator, text mining | PubMed |
| Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non-Small Cell Lung Cancers on the LIBRETTO-001 Trial. | Clin Cancer Res | 2021 | 34088726 | PubTator, text mining | PubMed |
| Modeling Clinical Responses to Targeted Therapies by Patient-Derived Organoids of Advanced Lung Adenocarcinoma. | Clin Cancer Res | 2021 | 34083237 | PubTator, text mining | PubMed |
| Proteins Marking the Sequence of Genotoxic Signaling from Irradiated Mesenchymal Stromal Cells to CD34+ Cells. | Int J Mol Sci | 2021 | 34072546 | PubTator, text mining | PubMed |
| Epidermal Growth Factor Receptor Expression and Resistance Patterns to Targeted Therapy in Non-Small Cell Lung Cancer: A Review. | Cells | 2021 | 34069119 | PubTator, text mining | PubMed |
| Fibroblast Growth Factor Receptors (FGFRs) and Noncanonical Partners in Cancer Signaling. | Cells | 2021 | 34068954 | PubTator, text mining | PubMed |
| Successful Alectinib Treatment for Carcinoma of Unknown Primary with EML4-ALK Fusion Gene: A Case Report. | Curr Oncol | 2021 | 34064158 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3799/papers?page=42